Two grams daily of oral acyclovir reduces the incidence of cytomegalovirus disease in CMV-seropositive liver transplant recipients
- 1 November 1997
- journal article
- Published by Frontiers Media SA in Transplant International
- Vol. 10 (6), 462-465
- https://doi.org/10.1111/j.1432-2277.1997.tb00725.x
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Randomised comparison of ganciclovir and high-dose acyclovir for long-term cytomegalovirus prophylaxis in liver-transplant recipientsThe Lancet, 1995
- A PROSPECTIVE RANDOMIZED TRIAL COMPARING SEQUENTIAL GANCICLOVIR-HIGH DOSE ACYCLOVIR TO HIGH DOSE ACYCLOVIR FOR PREVENTION OF CYTOMEGALOVIRUS DISEASE IN ADULT LIVER TRANSPLANT RECIPIENTSTransplantation, 1994
- Infection in the Organ Transplant RecipientPublished by Springer Science and Business Media LLC ,1994
- Cytomegalovirus disease after heart transplantation: Is acyclovir prophylaxis indicated?The Annals of Thoracic Surgery, 1993
- High-Dose Oral Acyclovir Reduces the Incidence of Cytomegalovirus Infection in Liver Transplant RecipientsThe Journal of Infectious Diseases, 1993
- Solid organ transplantation: Results and implications of acyclovir use in liver transplantsJournal of Medical Virology, 1993
- SUCCESSFUL PROPHYLAXIS OF CYTOMEGALOVIRUS DISEASE AFTER PRIMARY CMV EXPOSURE IN LIVER TRANSPLANT RECIPIENTSTransplantation, 1991
- A Randomized, Placebo-Controlled Trial of Oral Acyclovir for the Prevention of Cytomegalovirus Disease in Recipients of Renal AllograftsNew England Journal of Medicine, 1989